XML 83 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information (Tables)
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Schedule of Segment Data and Adjusted EBITDA
Segment data was as follows for the year ended December 31, 2020:
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$— $27,932 $— $27,932 
Cannabis extracts9,495 8,759 — 18,254 
Other— 533 — 533 
Net revenue9,495 37,224 — 46,719 
Share of loss from equity accounted investees— (4,510)— (4,510)
Interest revenue16 18,585 — 18,601 
Interest expense(34)(152)— (186)
Interest income (expense), net(18)18,433 — 18,415 
Depreciation and amortization234 2,638 — 2,872 
Income tax expense323 1,024 — 1,347 
Loss from discontinued operations— (650)— (650)
Adjusted EBITDA(28,019)(98,349)(20,885)(147,253)
Consolidated balance sheets
Total assets253,745 388,351 1,283,586 1,925,682 
Investments in equity accounted investees— 19,235 — 19,235 
Goodwill178,414 1,108 — 179,522 
Purchase of property, plant and equipment385 31,027 — 31,412 
Segment data was as follows for the year ended December 31, 2019:
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$— $15,020 $— $15,020 
Cannabis extracts3,364 5,338 — 8,702 
Other— 28 — 28 
Net revenue3,364 20,386 — 23,750 
Share of loss from equity accounted investees— (2,009)— (2,009)
Interest revenue29,207 — 29,213 
Interest expense— (1,244)— (1,244)
Interest income, net27,963 — 27,969 
Depreciation and amortization46 2,044 — 2,090 
Income tax expense— — — — 
Loss from discontinued operations— (363)— (363)
Adjusted EBITDA(1,703)(84,826)(11,779)(98,308)
Consolidated balance sheets
Total assets293,985 309,854 1,486,603 2,090,442 
Investments in equity accounted investees— 557 — 557 
Goodwill213,414 1,078 — 214,492 
Purchase of property, plant and equipment259 38,405 — 38,664 
Segment data was as follows for the year ended December 31, 2018:
United StatesRest of WorldCorporateTotal
Consolidated statements of net income (loss) and comprehensive income (loss)
Net revenue
Cannabis flower$— $9,210 $— $9,210 
Cannabis extracts— 2,732 — 2,732 
Other— 179 — 179 
Net revenue— 12,121 — 12,121 
Share of loss from equity accounted investees— (723)— (723)
Interest revenue— 220 — 220 
Interest expense— (139)— (139)
Interest income, net— 81 — 81 
Depreciation and amortization— 807 — 807 
Income tax expense— — — — 
Loss from discontinued operations— (894)— (894)
Adjusted EBITDA— (10,357)— (10,357)
Consolidated balance sheets
Total assets— 183,471 — 183,471 
Investments in equity accounted investees— 2,960 — 2,960 
Goodwill— 1,314 — 1,314 
Purchase of property, plant and equipment— 88,308 — 88,308 
Adjusted EBITDA is reconciled to net income (loss) as follows for the years ended December 31, 2020, 2019 and 2018:
(in thousands of U.S. dollars)Year ended December 31, 2020
USROWCorporate
Expenses
Total
Net income (loss)$(77,368)$32,671 $(30,573)$(75,270)
Adjustments
Interest expense (income), net18 (18,433)— (18,415)
Income tax expense323 1,024 — 1,347 
Impairment loss on goodwill and intangible assets40,000 — — 40,000 
Financing and transaction costs40 — — 40 
Gain on revaluation of derivative liabilities— (129,254)— (129,254)
Gain on disposal of other investments— (4,789)— (4,789)
Share of loss from equity accounted investees— 4,510 — 4,510 
Loss from discontinued operations— 650 — 650 
Other loss (income)20 1,814 — 1,834 
Review costs related to restatement of 2019 interim financial statements— — 9,688 9,688 
Share-based payments8,714 6,647 — 15,361 
Adjusted EBIT(28,253)(105,160)(20,885)(154,298)
Adjustments
Depreciation and amortization234 6,811 — 7,045 
Adjusted EBITDA(28,019)(98,349)(20,885)(147,253)
(in thousands of U.S. dollars)Year ended December 31, 2019
USROWCorporate
Expenses
Total
Net income (loss)$(3,070)$1,180,241 $(11,597)$1,165,574 
Adjustments
Interest income, net(6)(27,963)— (27,969)
Impairment loss on goodwill and intangible assets— — — — 
Repurposing charges— 7,268 — 7,268 
Financing and transaction costs117 32,091 — 32,208 
Gain on revaluation of derivative liabilities— (1,276,819)— (1,276,819)
Gain on disposal of other investments— (16,277)— (16,277)
Share of loss from equity accounted investees— 2,009 — 2,009 
Loss from discontinued operations— 363 — 363 
Other loss (income)182 (197)(182)(197)
Share-based payments900 10,719 — 11,619 
Adjusted EBIT(1,877)(88,565)(11,779)(102,221)
Adjustments
Depreciation and amortization174 3,739 — 3,913 
Adjusted EBITDA$(1,703)$(84,826)$(11,779)$(98,308)

(in thousands of U.S. dollars)Year ended December 31, 2018
Net income (loss)$(21,817)
Adjustments
Interest income, net(81)
Loss (gain) on disposal of other investments(164)
Share of loss (income) from equity accounted investees723 
Loss from discontinued operations894 
Share-based payments8,151 
Adjusted EBIT(12,294)
Adjustments
Depreciation and amortization1,937 
Adjusted EBITDA$(10,357)

Sources of net revenue were as follows:
Year ended December 31,
20202019
Cannabis flower$27,932 $15,020 
Cannabis extracts18,254 8,702 
Other533 28 
Net revenue$46,719 $23,750 
Schedule of Revenue from External Customers by Geographic Areas
Net revenue attributed to a geographic region based on the location of the customer were as follows:
Year ended December 31,
20202019
Canada$34,538 $20,202 
United States9,495 3,364 
Other countries2,686 184 
Total$46,719 $23,750 
Schedule of Long-lived Assets by Geographic Areas
Property, plant and equipment assets were physically located in the following geographic regions:
As of December 31,
20202019
Canada$162,163 $139,160 
United States2,293 2,103 
Other countries23,143 18,685 
Total$187,599 $159,948